Has Aarush Manchanda, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,339 in general payments to Aarush Manchanda, MD across 13 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Aarush Manchanda, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Aarush Manchanda, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Aarush Manchanda, MD

Cardiovascular Disease · Monterey, CANPI 1609027986

Payments from drug & device makers

$1,339in general payments, 2019–2025

Across 13 payments — averaging $103.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Heartflow, Inc.$619
Abbott$415
E.r. Squibb & Sons, L.L.C.$306

What the payments were for

Food & beverage$1,339100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Heartflow, Inc.	5	$619
Abbott	4	$415
E.r. Squibb & Sons, L.L.C.	4	$306

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,339 in reported general payments places this provider in the 40th percentile of 2,184 cardiovascular disease providers in California.

See all cardiovascular disease providers in California →

Medicare billing

Part B allowed, 2024

$347,369

Medicare patients

2,295

Services billed

4,796

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	240	$286,637
Repatha SureclickEvolocumab	37	$39,862
JardianceEmpagliflozin	32	$39,642
EntrestoSacubitril/Valsartan	22	$28,033
XareltoRivaroxaban	18	$23,607
Praluent PenAlirocumab	11	$14,838
Rosuvastatin Calcium	486	$10,108
Metoprolol Succinate	487	$8,133
Ezetimibe	143	$5,991
Midodrine Hcl	51	$3,913
Flecainide Acetate	107	$3,767
Bumetanide	55	$3,627
Telmisartan	55	$2,642
Atorvastatin Calcium	229	$2,510
Amiodarone Hcl	44	$2,291

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Monterey

Ted LoveHillsborough$102.8M
Matthew BudoffTorrance$11.3M
Lori DanielsSan Diego$10.2M
Paul KurthSanta Barbara$6.1M
Michael BlumSan Francisco$5.5M
Tony ChouSan Francisco$5.2M
Jason RogersSacramento$5.1M
Yu-Ping WangStanford$3.8M
Yogesh PaliwalPomona$3.3M
Farhad RafiiWest Hills$3.2M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →